Kronox Lab Sciences Share Price Today | Stock Price & Kronox Lab Sciences Share Screener
As of August 24, 2026, the live Kronox Lab Sciences share price (NSE: KRONOX) is ₹205.36 on NSE and ₹184.00 on BSE, down 4.56% from the previous close, with shares trading between ₹203.00 and ₹217.66 in today's trading session, and a 52-week range of ₹97.02–₹215.18. Track KRONOX market cap trends to gauge the company's total market size. Use the Kronox Lab Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Kronox Lab Sciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹112 and net income of ₹28, with EBITDA of ₹41, an operating margin of 33.0% and a profit margin of 25.0%.
Kronox Lab Sciences Share Price Chart
Track the current stock price of Kronox Lab Sciences with an interactive chart. Analyse KRONOX share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Kronox Lab Sciences stock quote in one place.
The quote of ₹205.36 sits between the 52-week low of ₹97.02 and the 52-week high of ₹215.18, and the latest session moved -4.56% from the previous close.
Kronox Lab Sciences Company Profile - Fundamental Screener
Screen Kronox Lab Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KRONOX shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Chemicals & Petrochemicals industry, and it trades under ISIN INE0ATZ01017.
Company Details
Classification
Identifiers and Leadership
Kronox Lab Sciences Balance Sheet Screener
Screen KRONOX balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹128, up from ₹99 in 2025.
Latest statistics put total assets at ₹128 and shareholder funds at ₹116, with a leverage ratio of 0.01.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Assets |
|||||||
| Total Assets | 128 | 99 | 74 | 54 | 57 | 38 | 34 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 29 | 28 | 26 | 16 | 11 | 9 | 6 |
Liabilities |
|||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 0 | 0 | 1 | 3 | 3 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||
| Total Equity | 116 | 90 | 66 | 45 | 40 | 27 | 23 |
| Share Capital | 37 | 37 | 37 | 37 | 0 | 0 | 0 |
| Reserves & Surplus | 79 | 53 | 29 | 8 | 40 | 27 | 23 |
Kronox Lab Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Kronox Lab Sciences income statement and profit fundamentals. Analyze KRONOX quarterly results. Kronox Lab Sciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹112 and net profit was ₹28, equal to earnings per unit of ₹7.70, at an operating margin of 33%.
In that period expenses were ₹72, interest cost ₹0 and tax ₹10. The next period listed, 2026-March, shows revenue of ₹106 and net profit of ₹28.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||
| Revenue | 112 | 106 | 103 | 91 | 98 | 83 | 63 | 52 |
| Expenses | 72 | 67 | 67 | 62 | 74 | 63 | 48 | 39 |
Operating Costs and Margins | ||||||||
| EBITDA | 41 | 40 | 36 | 30 | 24 | 21 | 16 | 13 |
| Operating Profit % | 33.00% | 34.00% | 33.00% | 32.00% | 23.00% | 24.00% | 24.00% | 23.00% |
| Depreciation | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | ||||||||
| Profit Before Tax | 38 | 37 | 34 | 29 | 22 | 18 | 13 | 12 |
| Tax | 10 | 10 | 9 | 7 | 6 | 5 | 4 | 3 |
| Net Profit | 28 | 28 | 26 | 21 | 16 | 14 | 10 | 9 |
| EPS | 7.70 | 7.50 | 6.90 | 5.81 | 4.29 | 3.49 | 2.40 | 343.75 |
Kronox Lab Sciences Cash Flow Screener - Liquidity Fundamentals
Screen KRONOX cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹24.
Over the same period, investing activities used ₹24 and financing activities provided ₹0.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | |||||||
| Operating Activities | 24 | 31 | 17 | 20 | 9 | 11 | 5 |
| Investing Activities | -24 | -28 | -17 | -7 | -8 | -3 | -4 |
Financing and Net Cash | |||||||
| Financing Activities | 0 | -2 | 0 | -13 | -1 | -7 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
Kronox Lab Sciences Shareholding Pattern Screener
See Kronox Lab Sciences shareholding pattern with promoter, FII, and DII holdings. Check Kronox Lab Sciences promoter holding and ownership changes for KRONOX on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Sept, promoters held 64.26%, foreign institutions 0.10%, domestic institutions 2.54% and the public 28.55%, spread across 29,776 shareholders.
The shareholder count was 29,776 in 2026-Sept, compared with 32,479 in 2026-Jun.
| Item | 2026-Sept | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Jan |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 64.26% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 100.00% |
Institutional Investors | ||||||||
| FII Holding | 0.10% | 0.04% | 0.08% | 0.05% | 0.03% | 0.03% | 0.04% | 0.00% |
| DII Holding | 2.54% | 2.07% | 2.05% | 2.00% | 1.93% | 1.71% | 2.20% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 28.55% | 20.82% | 20.98% | 21.13% | 21.20% | 21.41% | 20.54% | 0.00% |
| Other Holding | 4.55% | 2.85% | 2.68% | 2.62% | 2.63% | 2.64% | 3.01% | 0.00% |
| Shareholder Count | 29,776 | 32,479 | 33,469 | 34,608 | 35,780 | 37,569 | 37,922 | 9 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Kronox Lab Sciences. Kronox Lab Sciences dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 0.27%, compared with ₹0.50 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹0.50 and ₹0.50 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.50 | 0.27% |
| 2025-March | ₹0.50 | 0.52% |
| 2024-March | ₹0.50 | 0.35% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Kronox Lab Sciences Stock Index Membership - Nifty & Sensex
See which indices include Kronox Lab Sciences stock. Check KRONOX index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 2 indices, including BSE INDEX BSEIPO.
Among the benchmarks tracked are BSE INDEX BSEIPO, NIFTY IPO.
Complete Index List
Kronox Lab Sciences Market Events Screener - Corporate Actions
Get Kronox Lab Sciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Kronox Lab Sciences stock events that may affect KRONOX share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 5, 2026, with a record date of November 5, 2026.
It is followed by Annual General Meeting dated September 16, 2026 and Dividend dated September 9, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-05 | 2026-11-05 | Quarterly Result Announcement | NA | 1.12% |
| 2026-09-16 | 2026-09-16 | Annual General Meeting | NA | -1.89% |
| 2026-09-09 | 2026-09-09 | Dividend | ₹ 0.50 /share | 31.49% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | 3.35% |
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | 0.07% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -1.32% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -1.91% |
| 2025-08-18 | 2025-08-18 | Annual General Meeting | NA | -12.82% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -6.22% |
| 2025-08-08 | 2025-08-08 | Dividend | ₹ 0.50 /share | 18.95% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 0.63% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -1.75% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 8.62% |
| 2024-08-30 | 2024-08-30 | Annual General Meeting | NA | 23.41% |
| 2024-08-23 | 2024-08-23 | Dividend | ₹ 0.50 /share | 0.20% |
Kronox Lab Sciences Competitors Screener - Peer Stocks Comparison
Screen KRONOX competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Solar Industries | 169,796 | 72.90 | 9,966 | 30.94% | 1,737 | 44.30 |
| Pidilite Industries | 156,204 | 57.90 | 14,867 | 11.05% | 2,471 | 51.75 |
| SRF | 73,496 | 32.00 | 15,894 | 7.20% | 1,835 | 54.59 |
| Linde | 58,727 | 119.30 | 2,549 | -0.17% | 549 | 69.67 |
| Gujarat Fluorochemicals | 52,201 | 80.20 | 5,126 | 5.63% | 574 | 58.95 |
| Navin Fluorine International | 50,343 | 55.60 | 3,379 | 41.21% | 664 | 69.89 |
| Himadri Speciality Chemical | 28,319 | 32.20 | 4,832 | 3.60% | 755 | 44.85 |
| Aether Industries | 22,069 | 87.10 | 1,181 | 34.17% | 220 | 55.95 |
| Deepak Nitrite | 21,688 | 20.50 | 7,947 | -5.01% | 551 | 54.64 |
| Deepak Fertilisers & Petrochemicals | 18,225 | 14.70 | 11,609 | 12.11% | 739 | 70.36 |
Kronox Lab Sciences Company Announcements - News & Reports Screener
Screen KRONOX latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated November 13, 2026 and November 13, 2026.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Newspaper Publication | - | |
| 2026-11-13 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-11-13 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-11-06 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-11-06 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-11-05 | Updates on Open Offer | - |
| 2026-11-05 | Results - Financial Results For The Quarter And Half Year Ended September 30 2026 | - |
| 2026-11-05 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-11-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-10-30 | Board Meeting Intimation for Consider And Approve Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2026 | - |
| 2026-10-29 | Letter of Offer | - |
| 2026-10-23 | Disclosure Under Regulations SEBI (LODR) - Amendment Ot The Share Purchase Agreement | - |
| 2026-10-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On October 14 2026 | - |
| 2026-10-14 | Acquisition Of A Plant Adm. About 5000 Sq. Meters Located In A Dahej SEZ From Axiom Chemicals Private Limited | - |
| 2026-10-05 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-10-01 | Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations 2015 - Information And Update | - |
| 2026-09-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-30 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹205.36, within a 52-week range of ₹97.02 to ₹215.18. The P/E ratio is 24.00 and the P/B ratio is 5.32, with earnings per unit of ₹7.50. Market capitalisation stands at ₹673.29 Cr and the dividend yield is 0.27%. The company operates in the Chemicals sector, in the Chemicals & Petrochemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 7 balance sheet periods, 8 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.